Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Vicarious Surgical Inc.
Report date February 07, 2022 · Filed February 09, 2022
Jointly reported with Chelvey International Ltd, E15 Fund II, LP, Liang Philip
Section 16 reporting ended · disclosed 2022-02-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,988,121 |
Reported balance
After 2022-02-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2022-02-07 · Other · Disposed 6,649,744 · Balance 2,988,121 F1: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.
F2: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2022 Filed Feb 9, 2022 18:05 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 6,649,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-006211 · ownership.xml · nonDerivative · entry 1 Chelvey International Ltd · CIK 0001884829 · Former 10% Owner E15 Fund II, LP · CIK 0001885992 · Former 10% Owner Liang Philip · CIK 0001883781 · Director · Former 10% Owner Patnaik Shrikant · CIK 0001885980 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,988,121 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · balance_after: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 19:10 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 398,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-005113 · ownership.xml · nonDerivative · entry 1 Chelvey International Ltd · CIK 0001884829 · 10% owner E15 Fund II, LP · CIK 0001885992 · 10% owner Liang Philip · CIK 0001883781 · Director · 10% owner Patnaik Shrikant · CIK 0001885980 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,637,865 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · balance_after: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein. Read SEC document |
| September 17, 2021 Filed Oct 1, 2021 18:51 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 10,036,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-051193 · ownership.xml · nonDerivative · entry 1 Chelvey International Ltd · CIK 0001884829 · 10% owner E15 Fund II, LP · CIK 0001885992 · Sole Shareholder Liang Philip · CIK 0001883781 · Managing Partner Patnaik Shrikant · CIK 0001885980 · Principal Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,036,850 F1 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,043,028 Series A3 Preferred Stock of Vicarious. F2 · ownership.direct: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.